China SXT Pharmaceuticals (SXTC) Leases: 2023-2025
- China SXT Pharmaceuticals' Leases fell 29.94% to $149,278 in Q3 2025 from the same period last year, while for Sep 2025 it was $149,278, marking a year-over-year decrease of 29.94%. This contributed to the annual value of $176,648 for FY2025, which is 25.10% down from last year.
- According to the latest figures from Q3 2025, China SXT Pharmaceuticals' Leases is $149,278, which was down 15.49% from $176,648 recorded in Q1 2025.
- China SXT Pharmaceuticals' 5-year Leases high stood at $306,050 for Q1 2023, and its period low was $149,278 during Q3 2025.
- Over the past 3 years, China SXT Pharmaceuticals' median Leases value was $224,458 (recorded in 2024), while the average stood at $223,667.
- Data for China SXT Pharmaceuticals' Leases shows a maximum YoY dropped of 29.94% (in 2025) over the last 5 years.
- Over the past 3 years, China SXT Pharmaceuticals' Leases (Quarterly) stood at $261,108 in 2023, then declined by 18.40% to $213,068 in 2024, then fell by 29.94% to $149,278 in 2025.
- Its Leases was $149,278 in Q3 2025, compared to $176,648 in Q1 2025 and $213,068 in Q3 2024.
